Label: BENZONATATE capsule, gelatin coated

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated February 15, 2016

If you are a consumer or patient please visit this version.

  • DESCRIPTION

  • CLINICAL PHARMACOLOGY

  • INDICATIONS AND USAGE

  • WARNINGS

  • CONTRAINDICATIONS

  • PRECAUTIONS

  • ADVERSE REACTIONS

  • OVERDOSAGE

  • DOSAGE AND ADMINISTRATION

  • HOW SUPPLIED

  • PRODUCT PACKAGING

    BENZONATATE200 mg

  • INGREDIENTS AND APPEARANCE
    BENZONATATE 
    benzonatate capsule, gelatin coated
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:61919-763(NDC:51224-001)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZONATATE (UNII: 5P4DHS6ENR) (BENZONATATE - UNII:5P4DHS6ENR) BENZONATATE200 mg
    Inactive Ingredients
    Ingredient NameStrength
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
    GELATIN (UNII: 2G86QN327L)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    Product Characteristics
    ColoryellowScoreno score
    ShapeOVALSize11mm
    FlavorImprint Code N01
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:61919-763-2020 in 1 BOTTLE; Type 0: Not a Combination Product02/15/2016
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20276502/15/2016
    Labeler - DIRECT RX (079254320)
    Establishment
    NameAddressID/FEIBusiness Operations
    DIRECT RX079254320repack(61919-763)